From: Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
Methotrexate trial
Meloxicam trial
JADAS-71
JADAS-27
JADAS-10
CHAQ
0.46
0.50
0.51
0.44
0.43
0.45
DAS28
0.78
0.80
0.79
0.74
0.70
CDAI
0.88
0.86
0.72
0.87
0.75